Quince Therapeutics, Inc.
QNCX
Revenue
0.00
0.000.00%
-Assets
134.83M
▼-24.46M▼-15.36%
3 Months ChangeLiabilities
87.86M
▲2.75M▲3.23%
3 Months ChangeFree Cash Flow
-8.39M
▼-4.69M▼-126.50%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0001662774-24-000005
2024-08-13
Form 8-K
ID: 0001662774-24-000004
2024-06-21
Form 8-K
ID: 0001193125-24-165631
2024-06-06
Form 8-K
ID: 0001193125-24-156202
2024-05-13
Form 10-Q
ID: 0000950170-24-058201
2024-02-15
Form 8-K
ID: 0001193125-24-037521
2024-01-29
Form 8-K
ID: 0001193125-24-018071
2024-01-03
Form 8-K
ID: 0001193125-24-001482
2023-12-22
Form 8-K
ID: 0001193125-23-302116
2023-12-08
Form 8-K
ID: 0001193125-23-291671